Zaneta Odrowaz

Company: Attovia Therapeutics

Job title: Chief Business Officer

Bio:

Dr. Zaneta Odrowaz is the Chief Business Officer and Co-Founder of Attovia Therapeutics, where she leads business and corporate development. With a Ph.D. in molecular biology, she brings extensive experience in translating scientific innovation to the creation of therapeutics. At Attovia, Dr. Odrowaz is instrumental in advancing the strategic footprint of the company’s proprietary ATTOBODY® platform, which is designed to develop multispecific biologics for immune-mediated diseases, as well as the company’s programs in dermatology and IBD. Her leadership has been pivotal in securing over $250 million in funding, including a recent $90 million Series C, to propel Attovia’s innovative pipeline. 

Seminars:

Uncovering Modality, Precision Targeting & Global Partnership Synergies to Advance Autoimmune Combination Therapy Innovations 3:00 pm

Discussing optimal modality combinations, considering checkpoint agonism, bispecific, monoclonal and fixed dose oral approaches, to safety tailor combinations for complex autoimmune diseases, including IBD and RA Evaluating the balance of known and novel targets to align with safety profiles and unmet patient needs Exploring partnership opportunities with the rapidly expanding bispecific market in Asia and…Read more

day: Day Two